Project Details
Projekt Print View

Investigation of therapeutic targets of altered Hippo-signalling in liver cancer

Subject Area Pathology
Term from 2012 to 2014
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 215611262
 
Final Report Year 2015

Final Report Abstract

The p53 tumor suppressor coordinates a series of anti-proliferative responses that restrict the expansion of malignant cells and, as a consequence, p53 is lost or mutated in the majority of human cancers. We could show that loss of p53 enables dedifferentiation of mature hepatocytes into nestin-positive progenitor-like cells, which are poised to differentiate into hepatocellular carcinomas (HCCs) or cholangiocarcinomas (CCs) in response to lineage-specific mutations that target Wnt and Notch signaling, respectively. Moreover, our results demonstrate that p53 restricts expression of the stem and progenitor cell-associated protein nestin in an Sp1/3 transcription factor-dependent manner and that nestin is required for tumor initiation in vivo. Therefore, we uncover an unexpected role for p53 dependent tumor suppression in restricting dedifferentiation of terminal differentiated cells.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung